Here's the live share price of Sun Pharmaceutical Industries along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Sun Pharmaceutical Industries has gained 22.21% CAGR. Over the past year, the corresponding return has been -1.35%.
Sun Pharmaceutical Industries’s current P/E of 37.56x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 0.27 | -1.70 | 0.58 | 5.88 | -1.45 | 19.25 | 22.18 |
| Divi's Laboratories | -0.62 | -4.90 | -7.79 | 3.04 | 4.04 | 29.97 | 10.47 |
| Torrent Pharmaceuticals | 0.45 | 2.95 | 6.47 | 12.48 | 27.39 | 38.69 | 25.73 |
| Cipla | 1.48 | -8.46 | -11.35 | -10.74 | -7.98 | 9.12 | 9.22 |
| Dr. Reddy's Laboratories | 1.78 | 3.40 | 4.89 | 3.10 | 2.96 | 11.80 | 5.45 |
| Lupin | 0.85 | 0.69 | 10.95 | 13.30 | 1.62 | 44.09 | 15.59 |
| Zydus Lifesciences | -1.56 | -0.69 | -6.15 | -6.98 | -7.84 | 23.37 | 13.66 |
| Mankind Pharma | -3.80 | -6.87 | -7.25 | -14.88 | -17.28 | 13.36 | 7.81 |
| Alkem Laboratories | 1.43 | -1.42 | 1.86 | 19.47 | 20.50 | 20.60 | 14.94 |
| Aurobindo Pharma | -6.99 | -2.75 | -1.09 | 8.33 | -3.09 | 34.51 | 3.34 |
| Biocon | -1.18 | -1.13 | -3.77 | 7.54 | -2.48 | 14.84 | -2.09 |
| Abbott India | 1.65 | -3.87 | -7.40 | -17.23 | -7.92 | 9.61 | 13.70 |
| Glenmark Pharmaceuticals | 0.34 | -2.76 | 7.08 | -4.17 | 29.63 | 69.94 | 31.06 |
| Laurus Labs | -0.70 | -7.02 | -3.23 | 16.58 | 54.93 | 41.71 | 21.95 |
| GlaxoSmithKline Pharmaceuticals | 6.89 | 8.52 | 2.47 | -3.17 | 21.55 | 27.65 | 12.49 |
| Anthem Biosciences | 11.39 | 9.50 | -4.08 | -10.26 | -7.40 | -2.53 | -1.53 |
| Ipca Laboratories | -0.43 | -6.60 | 6.07 | 6.75 | -1.28 | 17.75 | 7.70 |
| Ajanta Pharma | 0.58 | 5.92 | 14.58 | 9.38 | 11.44 | 33.86 | 19.35 |
| Gland Pharma | -1.31 | 9.75 | -0.65 | -3.46 | 26.38 | 12.51 | -4.06 |
| J B Chemicals & Pharmaceuticals | 0.76 | 1.74 | 5.28 | 11.72 | 13.74 | 24.38 | 28.78 |
Over the last one year, Sun Pharmaceutical Industries has declined 1.45% compared to peers like Divi's Laboratories (4.04%), Torrent Pharmaceuticals (27.39%), Cipla (-7.98%). From a 5 year perspective, Sun Pharmaceutical Industries has outperformed peers relative to Divi's Laboratories (10.47%) and Torrent Pharmaceuticals (25.73%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,686.54 | 1,683.03 |
| 10 | 1,647.66 | 1,667.83 |
| 20 | 1,660.36 | 1,671.69 |
| 50 | 1,726.63 | 1,696.91 |
| 100 | 1,705.25 | 1,701.23 |
| 200 | 1,691.97 | 1,697.45 |
In the latest quarter, Sun Pharmaceutical Industries remained same as its previous close in promoter holding, while DII stake increased to 20.83%, FII holding fell to 16.12%, and public shareholding moved down to 8.57% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 1,62,98,476 | 4.57 | 2,802.85 | |
| 1,35,61,085 | 4.7 | 2,332.1 | |
| 1,19,32,663 | 2.61 | 2,052.06 | |
| 75,27,584 | 3.72 | 1,294.52 | |
| 74,14,889 | 1.18 | 1,275.14 | |
| 62,56,349 | 13.02 | 1,075.9 | |
| 60,54,009 | 2.56 | 1,041.11 | |
| 59,60,937 | 1.31 | 1,025.1 | |
| 51,05,969 | 5.95 | 878.07 | |
| 48,27,054 | 1.18 | 830.11 |
* Excluding Index & Arbitrage Funds
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Date Time | Announcement |
|---|---|
| Feb 05, 2026, 1:18 AM IST | Sun Pharmaceutical - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Feb 03, 2026, 11:58 PM IST | Sun Pharmaceutical - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Feb 03, 2026, 12:36 AM IST | Sun Pharmaceutical - Sustainability Report For The Financial Year 2024-25 |
| Feb 01, 2026, 1:51 AM IST | Sun Pharmaceutical - Q3FY26 Earnings Call Audio Recording |
| Jan 31, 2026, 11:10 PM IST | Sun Pharmaceutical - Announcement under Regulation 30 (LODR)-Change in Directorate |
Sun Pharmaceutical Industries Ltd. is a Public Limited Listed company incorporated on 01/03/1993 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1993PLC019050 and registration number is 019050. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 23003.33 Cr. and Equity Capital is Rs. 239.93 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Sun Pharmaceutical Industries is ₹1,709.00 as on Feb 10, 2026.
The Sun Pharmaceutical Industries is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Sun Pharmaceutical Industries is ₹409,986.36 Cr as on Feb 10, 2026.
Today’s highest and lowest price of Sun Pharmaceutical Industries are ₹1,719.65 and ₹1,703.60.
The 52-week high/low is the highest and lowest price at which Sun Pharmaceutical Industries stock has traded in the past 52-week or nearly a year. The 52-week high of Sun Pharmaceutical Industries is ₹1,850.95 and 52-week low of Sun Pharmaceutical Industries is ₹1,547.25 as on Feb 10, 2026.
The Sun Pharmaceutical Industries has shown returns of 0.26% over the past day, -1.6% for the past month, 0.68% over 3 months, -1.35% over 1 year, 19.3% across 3 years, and 22.21% over 5 years.
P/E ratio of and PB ratio of Sun Pharmaceutical Industries are 37.56 and 5.27 on Feb 10, 2026. While the company gives a dividend yield of 0.94 per annum.